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2Abstract 
The thermogenic activity of brown adipose tissue (BAT) largely depends on the 
mitochondrial uncoupling protein 1 (UCP1), which is up-regulated by environmental 
alterations such as cold. Recently, CIDEA (cell death-inducing DNA fragmentation 
factor--like effector A) has also been shown to be expressed at high levels in the 
mitochondria of BAT. Here we examined the effect of cold on the mRNA and protein 
levels of CIDEA in interscapular BAT of conscious rats with regard to the sympathetic 
nervous system. Cold exposure (4°C for 3 h) elevated the plasma norepinephrine level
and increased norepinephrine-turnover in BAT. Cold exposure resulted in down-
regulation of the mRNA and protein levels of CIDEA in BAT, accompanied by up-
regulation of mRNA and protein levels of UCP1. The cold exposure-induced changes 
of CIDEA and UCP1 were attenuated by intraperitoneal pretreatment with propranolol 
(a non-selective β-adrenoreceptor antagonist) (2 mg/animal) or SR59230A (a selective 
β3-adrenoreceptor antagonist) (2 mg/animal), respectively. These results suggest that
acute cold exposure resulted in down-regulation of CIDEA in interscapular BAT by 
sympathetically activated β3-adrenoreceptor-mediated mechanisms in rats.
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3Introduction
CIDEA (cell death-inducing DNA fragmentation factor--like effector A) was 
originally identified by their sequence similarity to the N-terminal region of the 
apoptotic DNA fragmentation factor DFF45 [1]. Recently, CIDEA has been shown to 
have roles in energy homeostasis. Human CIDEA is highly expressed in white adipose 
tissue and CIDEA inhibits basal lipolysis in human adipocyte [2]. CIDEA gene V115F 
polymorphism is also reported to be associated with obesity in humans [3].
Cidea is particularly expressed at high levels in the mitochondria of mice brown 
adipose tissue (BAT) [4]. BAT is the site of energy dissipation linked to heat 
production (thermogenesis) in rodents [5,6], human newborns and also adult humans 
[7] by uncoupling protein 1 (UCP1) expressing in the mitochondria of BAT, which 
causes conversion of the mitochondrial proton-motive force of ATP synthesis into heat 
[8]. Interestingly, Cidea-null mice exhibit higher energy expenditure with enhanced 
lipolysis in BAT [4]. This result suggests an important role of CIDEA for 
thermogenesis in BAT, however it is uncertain whether expression of the Cidea gene is 
changed by cold exposure, which triggers BAT thermogenesis. In the present study, 
therefore, we aimed to investigate whether cold exposure changes CIDEA expression
and the expression mechanisms of CIDEA in the rat interscapular BAT with regard to 
the sympathetic nervous system densely innervating the BAT.
4Materials and methods
  Materials. Anti-CIDEA polyclonal antibody (pAb), anti-UCP1 pAb and anti--
tubulin pAb were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). 
SR59230A (3-(2-ethylphenoxy)-1-[[(1S)-1,2,3,4-tetrahydronaphth-1-yl]amino]-(2S)-2-
propanol oxalate), -methyl-p-tyrosine (AMPT) and all other reagents were purchased
from Sigma-Aldrich (St Louis, MO, USA). All reagents for norepinephrine
measurement were purchased from Nacalai Tesque (Kyoto, Japan).
  Animals. Male Wistar rats weighing about 350 g were maintained in an air-
conditioned room at 22-24°C under a constant day-night rhythm for more than 2 weeks 
and given laboratory chow (CE-2, Clea Japan, Hamamatsu, Japan) and water ad 
libitum. The experiments were conducted in compliance with the guiding principles for 
the care and use of laboratory animals approved by Kochi University.
Experimental protocols. Experiment-1 (Figs. 1A and 2): Rats were anesthetized with 
pentobarbital (40 mg/kg, i.p.). The left femoral artery was catheterized with a PE-50 
tube for collecting blood samples. The catheter was filled with heparinized saline (100 
U/ml) and tunneled subcutaneously to exit at the back of neck [9]. One day after 
catheterization, conscious rats were transferred from their home cage to a new plastic 
cage. After a 2-h stabilization period, the first blood sample (250 µl) was collected and 
the cage was transferred to a cold room (4°C) or maintained in an air-conditioned room 
(23°C). The second blood sample was withdrawn 3 h after exposure to each 
temperature. After the second blood sampling, rats were decapitated and bilateral 
interscapular BAT were immediately removed and stored at -80°C until use for RNA 
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experiment and plasma samples were prepared immediately after the end of BAT 
sampling. Experiment-2 (Fig. 1B): Conscious rats not having undergone an operation 
were transferred from their home cage to a new plastic cage. After a 2-h stabilization 
period, rats were given an intraperitoneal injection of AMPT (250 mg/kg) and the cage 
was transferred to a cold room (4 °C) or maintained in an air-conditioned room (23°C).
After 3-h exposure to each temperature, rats were decapitated and bilateral 
interscapular BAT was immediately removed for norepinephrine measurement. To 
measure norepinephrine content in BAT at 0 h, rats were decapitated immediately after 
the injection of AMPT. Experiment-3 (Figs. 3 and 4): Conscious rats not having 
undergone an operation were transferred from their home cage to a new plastic cage. 
After a 2-h stabilization period, rats were given an intraperitoneal injection of 
propranolol (2 mg/kg) or SR59230A (2 mg/kg). Thirty min after the injection, the cage 
was transferred to a cold room (4°C) or maintained in an air-conditioned room (23°C).
After 3-h exposure to each temperature, rat was decapitated and bilateral interscapular 
BAT was immediately removed and stored at -80°C until use for RNA preparation and
Western blotting.
  Norepinephrine measurement in the plasma and interscapular BAT. The BAT was 
homogenized in 20 ml of 0.4 M perchloric acid containing 18.6 mg of disodium EDTA, 
200 µl of 2% sodium pyrosulfite solution and 500 ng of 3,4-dihydroxybenzylamine
(DHBA) as an internal standard. The homogenate was centrifuged for 10 min at 14,000 
g at 4°C. The supernatant was analyzed to determine the tissue level of norepinephrine 
[10]. Norepinephrine in the plasma and the supernatant of tissue homogenate was
6extracted and electrochemically assayed with high performance liquid chromatography 
as described previously [10,11].
  RT-PCR. Total RNA was isolated from BAT using TRIZOL reagent (Invitrogen,
Tokyo, Japan). RT-PCR was performed as described previously [12]. The primers used 
were as follows: rat Cidea upstream primer, 5'-GCTGGTGCTGGAGGAG-3'; rat 
Cidea downstream primer, 5'-CTGTCCCGTCATCTGTGC-3'; rat Ucp1 upstream 
primer, 5'-GTCTTAGGGACCATCACCA-3'; rat Ucp1 downstream primer, 5'-
CCAGTGTAGCGGGGTTTG-3'; rat β-actin upstream primer, 5'-
TTGTAACCACCTGGGACGATATGG-3'; rat β-actin downstream primer, 5'-
GATCTTGATCTTCATGGTGCTAG-3'. The PCR products were resolved by 
electrophoresis on a 2% agarose gel in 0.5 x Tris acetate-EDTA. The gels were stained 
with ethidium bromide and photographed. Band densities were obtained by using the 
KODAK 1D image analysis software program.
  Western blotting. The interscapular BAT was homogenized in a solution containing 
10 mM Tris-HCl and 1 mM EDTA (pH 7.4). After centrifugation (1,500 g for 5 min, at 
4°C), the fat cake was discarded and the middle layer (fat-free extract) was used for 
Western blotting [13]. The fat-free extract was added to the sodium dodecyl sulfate 
(SDS) sample buffer. The total lysates were then boiled for 5 min. SDS-
polyacrylamide gel electrophoresis and Western blotting were performed as described 
previously [12].
  Statistics. All values were expressed as the means±S.E.M. The data were analyzed 
by repeated-measure analysis of variance (ANOVA), followed by post-hoc analysis 
with the Bonferroni method for comparisons among all values (Fig. 1B). When only 
two means were compared, an unpaired Student’s t-test or Welch’s t-test was used 
7(Figs. 1A, 2, 3 and 4). P values less than 0.05 were taken to indicate statistical 
significance.
8Results
Effect of acute cold exposure on the plasma norepinephrine level and norepinephrine 
content in interscapular BAT
In preliminary studies in rats, we monitored the time course of plasma 
norepinephrine level for 4 h after cold exposure (4°C). The norepinephrine level 
increased at 0.5 h and reached a plateau at 1.5 h after cold exposure in rats (data not 
shown). Therefore, we examined at 3 h after cold exposure in the following 
experiments. Acute cold exposure (4°C for 3 h) significantly increased plasma 
norepinephrine level (from 290±48 to 893±117 pg/ml), although maintaining at 23°C
for 3 h had no effect on the plasma norepinephrine level (261±27 pg/ml at 0 h, 271±21 
pg/ml at 3 h) in rats (Fig. 1A). 
By blocking norepinephrine biosynthesis by pretreatment with AMPT (a tyrosine 
hydroxylase inhibitor), norepinephrine contents in interscapular BAT of rats exposed 
to 4°C for 3 h and maintained at 23°C for 3 h were significantly lower than those in
BAT before exposure to each temperature (at 0 h) (1.29±0.02 ng/mg tissue at 0 h, 
0.90±0.07 ng/mg tissue at 23°C for 3 h, 0.29±0.01 ng/mg tissue at 4°C for 3 h) (Fig. 
1B). However, norepinephrine content in the BAT of rats exposed to 4°C was lower 
than that of rats maintained at 23°C, at 3 h after exposure to each temperature (Fig. 1B). 
Effect of acute cold exposure on CIDEA and UCP1 expression levels of mRNA and 
protein in interscapular BAT
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h), mRNA levels of Cidea in the BAT of rats exposed to 4°C were significantly lower 
than those maintained at 23°C, while mRNA levels of Ucp1 in the BAT of rats 
exposed to 4°C were significantly higher than those maintained at 23°C (Fig. 2, A and 
B). These tendencies in mRNA levels of Cidea and Ucp1 were also observed in protein 
levels of CIDEA and UCP1 in the BAT of rats exposed to 4°C and maintained at 23°C, 
respectively (Fig. 2C).
Effect of propranolol on the acute cold exposure-induced changes of CIDEA and 
UCP1 expression levels in the interscapular BAT
Even in the vehicle (saline)-pretreated rats, the levels of Cidea and CIDEA in the 
BAT of rats exposed to 4°C for 3 h were also significantly lower than those maintained 
at 23°C for 3 h, while the levels of Ucp1 and UCP1 in the BAT of rats exposed to 4°C 
for 3 h were significantly higher than those maintained at 23°C for 3 h (Fig. 3, A, B 
and C). 
In the propranolol (a non-selective β-adrenoreceptor antagonist) (2 mg/kg, i.p.)-
pretreated rats, CIDEA and UCP1 expression levels of mRNA and protein in the BAT 
of rats exposed to 4°C for 3 h were almost the same as those maintained at 23°C for 3 
h (Fig. 3, A, B and C).
Effect of SR59230A on the acute cold exposure-induced changes of CIDEA and UCP1 
expression levels in the interscapular BAT
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In the vehicle (10% dimethylsulfoxide in saline)-pretreated rats, the levels of 
Cidea and CIDEA in the BAT of rats exposed to 4°C for 3 h were also significantly 
lower than those maintained at 23°C for 3 h, while the levels of Ucp1 and UCP1 in the 
BAT of rats exposed to 4°C for 3 h were significantly higher than those maintained at 
23°C for 3 h (Fig. 4, A, B and C).
In the SR59230A (a selective β3-adrenoreceptor antagonist [14]) (2 mg/kg, i.p.)-
pretreated rats, CIDEA and UCP1 expression levels of mRNA and protein in the BAT 
of rats exposed to 4°C for 3 h were almost the same as those maintained at 23°C for 3 
h (Fig. 4, A, B and C).
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Discussion
Sympathetic innervations to the rat interscapular BAT are responsible for the 
regulation of thermogenesis in response to cold exposure [15]. It has been reported that 
cold exposure increases plasma norepinephrine level by activating exclusively the 
sympathetic nervous system [16]. In the present study, an increase in plasma 
norepinephrine was also observed by acute cold exposure in conscious rats. However, 
plasma norepinephrine can reflect not only the release from sympathetic nerves but 
also the secretion from norepinephrine-containing cells in the adrenal medulla [17]. 
Therefore, we further tried to determine the sympathetic outflow by assessing 
norepinephrine turnover after blockage of norepinephrine biosynthesis with tyrosine 
hydroxylase inhibitor AMPT [18]. In the AMPT-treated rats, acute cold exposure 
markedly decreased the norepinephrine content in BAT, indicating the activation of 
sympathetic nerves innervating the rat BAT.
The sympathetic activation in BAT has been shown to promote thermogenesis, 
differentiation and cell proliferation of brown adipocytes [6]. The thermogenic activity 
of BAT largely depends on UCP1, since Ucp1-deficient mice undergo a rapid decrease 
in body temperature during cold exposure [19]. In the present study, mRNA and 
protein levels of UCP1 were up-regulated in interscapular BAT exposed to acute cold
in rats, as previously described [20]. It has been well shown that UCP1 up-regulation 
induced by cold exposure is mediated by activation of β-adrenoreceptors, and systemic 
pretreatment with antagonists of the receptors has been reported to reduce BAT 
thermogenesis [21]. Brown adipocytes express a combination of adrenoreceptor 
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isoforms (1, β1, β2 and β3) with β3-adrenoreceptors being the most abundant [22], and 
the β3-adrenoreceptors have been show to be involved in UCP1 up-regulation and BAT 
thermogenesis [23,24]. In the present study, systemic pretreatments with propranolol 
and SR59230A effectively attenuated the UCP1 up-regulation induced by acute cold 
exposure in interscapular BAT in rats. These results suggest that the acute cold 
exposure-induced up-regulation of UCP1 expression in BAT is mediated by β3-
adrenoreceptors in rats.
In contrast to UCP1, acute cold exposure induced down-regulation of the mRNA 
and protein levels of CIDEA in interscapular BAT in the present study. The down-
regulation of CIDEA was also effectively attenuated by propranolol and SR59230A.
These results suggest that the acute cold exposure-induced down-regulation of CIDEA 
expression in BAT is also mediated by β3-adrenoreceptors in rats. Recently, several 
expression mechanisms of the CIDEA gene have been reported. In differentiated brown 
adipocytes, CIDEA protein can be degraded by the ubiquitin-proteasome system [25], 
which seems to be inactivated by cold exposure in BAT [26], thereby suggesting a 
possibility that cold exposure up-regulates CIDEA protein levels. However, in the 
present experiment, CIDEA in both levels of mRNA and protein was down-regulated 
by acute cold exposure, the down-regulation of CIDEA occurred by a mechanism other 
than the ubiquitin-proteasome system. The expression and promoter activity of CIDEA
have been shown to be induced by peroxisome proliferator-activated receptor gamma 
coactivator 1 (PGC-1) [27], which can also stimulate Ucp1 expression [6,20]. Since 
CIDEA and UCP1 expression levels were inversely changed by acute cold exposure in 
BAT in the present study, a mechanism other than PGC-1 may be involved in the 
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acute cold exposure-induced down-regulation of CIDEA in BAT. Tumor necrosis 
factor- (TNF-) has been shown to reduce the transcriptional activity of the human 
CIDEA promoter [28]. Actually, TNF- treatment with human adipocytes decreased 
CIDEA gene expression [2]. In addition, norepinephrine induces the release of TNF-
in mouse macrophages [29]. These findings suggest a possibility that TNF- released 
by activation of the sympathetic nervous system induces down-regulation of CIDEA 
expression in response to acute cold exposure in rat BAT. However, the precise 
inhibitory mechanisms of rat Cidea gene expression in BAT are largely undefined.
Further studies are required to clarify the mechanisms of cold exposure-induced down-
regulation of CIDEA expression in BAT.
Both CIDEA and UCP1 are highly expressed in mice BAT. Interestingly, co-
expression of Cidea and Ucp1 in yeast resulted in inhibition of UCP1 activity of 
conversing the proton-motive force into heat and Cidea-null mice had higher body 
temperature when exposed to cold than wild-type mice [4]. Furthermore, treatment 
with a very low calorie diet induced an increase in CIDEA gene expression in human 
white adipose tissue [30]. These findings suggest that CIDEA plays an inhibitory role 
in thermogenesis and energy expenditure in adipose tissue by negatively modulating 
the activity of UCP1. As shown in the present study, CIDEA and UCP1 expression 
levels in BAT are inversely changed by acute cold exposure, indicating a reasonable 
mechanism in adaptation to cold environments by activation of BAT thermogenesis
through not only increasing UCP1 but also decreasing CIDEA.
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In summary, we demonstrated here for the first time that CIDEA is down-
regulated in response to acute cold exposure in rat interscapular BAT by
sympathetically activated β3-adrenoreceptors.
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Legends to figures
Fig. 1. Effect of acute cold exposure on the plasma norepinephrine level and 
norepinephrine content in interscapular brown adipose tissue (BAT). (A) Plasma level 
of norepinephrine (NE). Conscious rats were either exposed to 4°C or maintained at 
23°C for 3 h, and blood samples were collected twice at 0 h (before) and 3 h through 
an arterial catheter. Each value represents the mean±S.E.M. (n=6/group).
*Significantly different from the values at 0 h with an unpaired Student’s t-test or
Welch’s t-test (P<0.05). (B) NE content in interscapular BAT. Conscious rats were
either exposed to 4°C or maintained at 23°C for 3 h after administration of AMPT (a 
tyrosine hydroxylase inhibitor) (250 mg/kg, i.p.) and the BAT were collected. NE 
content at 0 h was obtained immediately after the injection of AMPT. Each value 
represents the mean±S.E.M (n=4/group). Significant differences among all values were
determined with Bonferroni method (*P<0.05 compared with the values at 0 h, 
#P<0.05 compared with the values at 23°C).
Fig. 2. Effect of acute cold exposure on CIDEA and UCP1 expression levels of mRNA 
and protein in interscapular BAT. Conscious rats were either exposed to 4°C or 
maintained at 23°C for 3 h and interscapular BAT were isolated. (A) RT-PCR analysis 
of Cidea and Ucp1 expression in the BAT. (B) Quantitation of mRNA signal intensity
relative to the internal standard, β-actin. Each value represents the mean±S.E.M 
(n=6/group). *Significantly different from the group maintained at 23°C with an 
unpaired Student’s t-test or Welch’s t-test (P<0.05). (C) CIDEA and UCP1 levels in
the BAT were detected by Western blotting.
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Fig. 3. Effect of propranolol on the acute cold exposure-induced changes of CIDEA 
and UCP1 expression levels in interscapular BAT. Conscious rats pretreated with 
propranolol (a non-selective antagonist of β-adrenoreceptors) (2 mg/kg, i.p.) or vehicle 
(1 ml/kg of saline, i.p.) were either exposed to 4°C or maintained at 23°C for 3 h, and
BAT was isolated. (A) RT-PCR analysis of Cidea and Ucp1 expression in BAT. (B) 
Quantitation of mRNA signal intensity relative to the internal standard, β-actin. Each 
value represents the mean±S.E.M (n=6/group). *Significantly different from the group
maintained at 23°C with an unpaired Student’s t-test or Welch’s t-test (P<0.05). (C) 
CIDEA and UCP1 levels in BAT were detected by Western blotting.
Fig. 4. Effect of SR59230A on the acute cold exposure-induced changes of CIDEA and 
UCP1 expression levels in the interscapular BAT. Conscious rats pretreated with 
SR59230A (a selective antagonist of β3-adrenoreceptors) (2 mg/kg, i.p.) or vehicle (1 
ml/kg of 10% dimethylsulfoxide in saline, i.p.) were either exposed to 4°C or 
maintained at 23°C for 3 h, and the BAT were isolated. (A) RT-PCR analysis of Cidea
and Ucp1 expression in BAT. (B) Quantitation of mRNA signal intensity relative to 
the internal standard, β-actin. Each value represents the mean±S.E.M (n=6/group). 
*Significantly different from the group maintained at 23°C with an unpaired Student’s 
t-test or Welch’s t-test (P<0.05). (C) CIDEA and UCP1 levels in BAT were detected 
by Western blotting.
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